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Abstract
Nutritional utilization of antioxidants, such as vitamins C, E, ß-Carotene and 
micronutrients, such as folate and zinc, have been shown to be critically essential 
for normal semen quality and reproductive function. However, it is still, a large 
knowledge gap exists concerning the role of antioxidants on semen parameters 
and the role in treatment of male subfertility. Therefore, the current review article 
designed to find out the positive effect of antioxidants on semen quality, alterations 
in physiological functions of spermatozoa and infertility treatment It is advisable 
that patients with oxidative DNA disruption should be asked to take a simple course 
of antioxidants prior to undertaking assisted reproduction treatment (ART). In 
conclusion, antioxidant may be employed as a potent antioxidant and may improve 
infertility treatment outcomes with ART.
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1. Introduction: The impact of oxidative stress on spermatozoa
ROS include a broad category of species including: a) Oxygen free radicals, such 
as superoxide anion (O2), hydroxyl radical (OH) and hyperoxyl radical (HOO). 
b) Non radical species, such as hypochlorous acid (HOCl) and hydrogen peroxide 
(H2O2). c) Reactive nitrogen species and free nitrogen radicals such as nitroxylion, 
nitrous oxide, peroxynitrite, etc. [1–3]. These ROS are generated during normal 
aerobic metabolism and their level increases under stress which reflects a basic 
health danger. Mitochondrion is the primary cell organelle involved in ROS produc-
tion. Besides, several endogenous cells and cellular components contribute towards 
the initiation and propagation of ROS [4, 5].
Overproduction of ROS or the deficiency of antioxidants provokes an imbalance 
between the per-oxidation and the anti-oxidation in the normal human body. This 
phenomenon is termed as Oxidative stress [6–8].
Subsequently, it leads to alterationsin peroxidation of lipid membranes of 
sperm, disrupting the structure of membrane receptors, enzymes, transport 
proteins, and causes an increase in the level of DNA fragmentation of sperm [9] 
(Figure 1).
ROS have a significant effect on the sperm plasma membrane and subsequent 
functional integrity of the sperm resulting in a loss of acrosome reaction [11], 
Antioxidants - Benefits, Sources, Mechanisms of Action
2
the sperm potential for fertilization [12], sperm motility and vitality [13, 14] as well 
as impair the sperm capacitation [15] (Figure 1).
Both seminal plasma and spermatozoa contain antioxidant systems able to 
detoxify the harmful effects of ROS. The imbalance between total antioxidant 
capacity and ROS generationin seminal fluid presents oxidative stress and is 
strongly correlated with male infertility [16].
In addition, insufficient penetration of the sperm into the oocyte in oligo-
spermia men with elevated levels of ROS has been identified [7]. Moreover, ROS 
concentrations are considerably elevated in semen samples from infertile men as 
compared with those of healthy controls, which has suggests that infertile men may 
benefit highly from antioxidant supplementation [17].
Several lifestyle, stress, and environmental factors encourage excessive free 
radical generation and oxidative stress, including: Air pollution, cigarette smoke, 
alcohol intake, toxins, bacterial, fungal, or viral infections, radiation, including 
extensive sun bathing, intense and lengthy exercise, which provoke tissue damage, 
antioxidant deficiency and finally enormous intake of antioxidants, such as vita-
mins C and E etc.
Hammadeh presented that the oxidative stress and smoking markers, (ROS), 
malondialdehyde, 8-Hydroxyguanosine (8-OHdG) and cotinine were significantly 
higher (P < 0.010) in smokers as compared to non-smokers [18].
In a second study, both fertile and infertile smokers presented elevated seminal 
ROS level [19].
Alcohol, known as ethyl alcohol or ethanol; EtOH, promotes ROS. These ROS 
ultimately interact with macromolecules, among them membrane lipids, generat-
ing aldehydes such as 4-Hydroxynonenal (4-HNE) and Malondialdehyde (MDA). 
It is also known that aldehydes and ROS can directly interact with both proteins 
and DNA, ultimately leading to transcription-repression of concrete genes. In 
fact, the impactof ROS and aldehydes seems to serve as key factor for these altera-
tions, partially affirmed by the fact that intake of antioxidants prevents these 
EtOH-induced cellular alterations [20].
The effect of oxidative stress on sperm quality has been studied extensively 
and estimated to be the problem in 25–87% of male infertility cases [21]. Another 
major driving hypothesis states that these conditions, by increasing reactive oxygen 
species (ROS) and nitrogen species (RONS), are capable of altering the balance 
of the redox status of both the steroidogenic cell population and the germ line cell 
Figure 1. 
Role of reactive oxygen species in male reproduction [10].
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populations, causing the disruption of the hypothalamic–pituitary–testicular axis 
and the impairment of sperm quality [22].
Therefore, the human body has developed a very concise defense system in 
which antioxidants play a very important role. Antioxidants are capable of decreas-
ing the generation of free radicals, slowing or inhibiting the oxidation and repairing 
the damage [23]. Mirończuk-Chodakowska also presented that ROS can serveas 
mediators and regulators of cell metabolism and apoptosis [23].
2.  Antioxidants and the sperm quality (count, motility and morphology) 
and function
Sperms are especially susceptible to oxidative damages due to the presence of 
excessive amounts of polyunsaturated fatty acids in the plasma membrane, making 
them highly vulnerable for lipid peroxidation by ROS, causing decreased flexibility 
of the sperm membrane and decreased tail motion [24]. Besides, the cytoplasm is 
extracted during the final stages of spermatogenesis, leaving behind the spermato-
zoa alone without these important enzymes to protect them from ROS altering the 
sperm DNA [24].
A Significant positive correlation has also been described between levels of 
reactive oxygen species (ROS) and percentage of spermatozoa with several types of 
abnormalities such as, abnormal heads, acrosome abnormalities, mid piece anoma-
lies, cytoplasmic droplets and tail defects [25].
In previous studies, it has been demonstrated that the generation of reactive 
oxygen species has been linked with loss of motility and a reduced capacity for 
sperm–oocyte fusion [26].
In addition, seminal oxidative stress is rather negatively correlated with  
sperm count, function, and motility, adversely interfering with fusion required for 
 successful fertilization [27].
Prospective studies have indicated that men with elevated levels of ROS have 
seven times less chance of fertilizing in comparison with men with low ROS levels. 
Moreover, ROS results in sperm cell damage and its high values have a negative 
correlation with sperm number and motility [28].
Other studies reveal that sperm exposed to elevated levels of ROS show reduc-
tion in viability and motility as confirmed through both conventional assessment 
and the utilization of computer-assisted sperm motility analysis [29, 30].
Antioxidant supplements are commercially available to assist treat male infertil-
ity, but research on its impact on semen quality and rates of pregnancy and live 
birth are rather very limited and controversial.
The male reproductive condition can be enhanced by supplementation of 
beneficial elements such as zinc or selenium which provide positive changes in 
sperm count and motility [31]. Melatonin, beta-carotene, or luteine also maintain 
high semen quality [32, 33]. Several studies have affirmed that higher intake of 
vitamin E, vitamin C, and beta –cartotine, is linked with improved sperm count 
motility, in both fertile and infertile men [34, 35].
Also, spermatozoa are dependent on antioxidants which already present in 
seminal plasma as ascorbic acid (vitamin C), α-tocopherol (vitamin E), glutathione 
(GSH), amino acids (taurine and hypotaurine), albumin, carnitine and carot-
enoids [36].
A clinical trial on the impact of antioxidants on male factor infertility enrolled 
a population of 171 couples. The male partner presented at least one abnormal 
reading concentration, mobility, morphology and DNA quality; the female partners 
presented normal fertility test results. Men received a placebo or an antioxidant 
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supplement comprising of vitamins C, E, D, selenium, L-carnitine, zinc, folic acid 
and lycopene from three to six months [37].
In this study, no statistically significant differences in sperm concentration, mobil-
ity, morphologically normal sperm and DNA quality between the placebo and anti-
oxidant groups after three months have been observed. Moreover, live birth rates did 
not differ at six months between the antioxidant (15%) and placebo (24%) groups.
3. Antioxidants and sperm DNA fragmentation and apoptosis
Spermatozoa chromatin is relatively tightly packed due to the positively charged 
protamine unlike histone in somatic cells [38]. This highly dense and stable struc-
ture decreases the capability of DNA disruption. Unfortunately, as spermatozoa 
have only a few repair mechanisms, DNA damage is generally encountered in 
human spermatozoa, even within the fertile donor population [39].
It has been presented that almost 40% of men searching for a fertility treatment 
are fertile and free of sperm oxidative DNA damage [40].
In fact, this topic was discussed in several studies. Mark et al. described that 
spermatozoa are especially prone to oxidative stress due to the elevated ROS level 
can provokea break down of sperm phospholipids and fatty acids [41].
Others have been illustrated that an increase degeneration of ROS by morpho-
logically abnormal spermatozoa and/or decreased antioxidant capacity of seminal 
plasma are possible reasons of DNA damage in these patients [42, 43].
Hammadeh et al., demonstrated that the ROS level in subfertile patients was 
significantly higher compared with normal subjects [18].
Besides, 8-hydroxydeoxyguanosine (8OHdG) is considered to be an important 
sensitive oxidative biomarker for evaluating oxidative sperm DNA damage, and its 
levels were found be significantly higher in infertile patients compared with normal 
ones [18, 44].
Defective spermatozoa are also postulated to retain high residual cytoplasm, 
allowing them to produce excessive reactive oxygen species (ROS), which, provided 
their incomplete chromatin packaging, causes DNA damage [45]. Therefore, DNA 
damage in spermatozoa is primarily related to oxidative stress [45].
Sperm DNA damage could be testicular or post-testicular [46]. These damages 
may include disruptions in spermatogenesis (e.g., genetic or developmental abnor-
malities) and testicular or post-testicular damage (e.g., gonadotoxins, hyperther-
mia, oxidants, and endocrine abnormalities). It has been postulated that protamine 
deficiency (with subsequent aberrant chromatin remodeling), reactive oxygen 
species and abortive apoptosis may be associated with sperm DNA damage [18, 47].
WalczakJędrzejowska described the damaging impact of oxidative stress on 
sperm cells including a reduction in activity of anti-oxidative mechanisms, disrup-
tion of DNA and accelerated apoptosis [48].
Another study demonstrated that oxidative parameters in the semen of infertile 
men were significantly rather higher than in fertile men, and a very high correla-
tion was observed between oxidative parameters, sperm ROS generation, and DNA 
fragmentation level [49].
Since sperm DNA disruption can be associated by oxidative and non-oxidative 
stress (caused by incomplete sperm protamination or aberrant apoptosis), the utili-
zation of DNA fragmentation tests may not be the perfect procedure for identifying 
individuals with high sperm DNA damage related to oxidative stress.
Therefore, the most ideal parameters to assess DNA damage might not be DNA 
fragmentation but sperm-oxidation level which indirectly interferes with DNA 
disruptions [50, 51].
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Antioxidants utilized as dietary supplements removed free radicals and decrease 
the degree of oxidative insult by improving the cellular redox equilibrium [52].
Several studies demonstrated positive results in the therapy of patients with 
moderate DNA damage exploiting oral antioxidants [42, 53, 54].
Greco and colleagues reportedan enhancement in DNA damage in 76% of 
patients with moderate DNA damage (≥15%) after oral intake with vitamins [53].
The beneficial impact of raised antioxidant consumption on sperm concentra-
tion and motility in the infertile patient population with no effect on sperm DNA 
integrity has also been observed [55].
The advantages of antioxidant therapy in male infertility are rather inconclusive 
with both a positive effect [53, 54] and no significant effect reported [56]. Also, 
Silver analyzed a cohort of fertile men and did not report any relationships between 
dietary antioxidant consumption (vitamins C, E or ß-carotene) and sperm DNA 
damage [56].
Treatment with antioxidant supplements is generally related with decreased 
levels of sperm DNA integrity and/or increased fertility potential [57].
The impactof these antioxidants in prohibiting sperm from endogenous ROS, 
gentle sperm processing and cryopreservation has yet not been established [58].
It is advisable that patients with oxidative DNA disruption should be asked 
to take a simple course of antioxidants prior to under taking assisted reproduc-
tion treatment. The utilization of antioxidants in decreasing sperm oxidative 
stress has been the topic of some 20 clinical trials over the last decade for a 
review [59].
Systematic review involving 29 studies evaluated the impact of oral antioxidant 
therapy on fertility outcomes and affirmed an overall positive effect of antioxidant 
supplementation on basic semen parameters, advanced sperm function, results of 
assisted reproductive therapy (ART), and live birth rate [60].
Oral supplementation of a either a single antioxidant or a combination of anti-
oxidants such as L-carnitine, L-acetyl carnitine, N-acetyl-cysteine, Coenzyme Q10, 
selenium, vitamin C, vitamin E, and lycopene has been reported to enhance semen 
parameters and sperm DNA integrity in idiopathic infertile men [61].
4. Types of antioxidants
Seminal plasma comprises of a number of antioxidant enzymes, such as, 
superoxide dismutase, glutathione peroxidase, glutathione reductase, and catalase, 
and also include non-enzyme antioxidants, such as vitamin C, vitamin E, beta 
carotenes, carotenoids, flavonoids and metal binding proteins such as albumin, 
ferritin, coenzyme Q10 and myoglobin, which serve as antioxidant by inactivating 
pro-oxidant transition metal ions (Figure 2) [62–64].
The non- enzymatic antioxidants may protect the spermatozoa from oxidative 
DNA and membrane disruption by decreasing the singlet oxygen and the detrimen-
tal effect of lipid peroxidation on sperm [65].
4.1 Enzymatic natural antioxidants
The male reproductive system has an endogenous antioxidant for shielding 
spermatozoa from oxidative insult and these are categorized into enzymatic and 
non-enzymatic [1]. The enzyme system includes ssuperoxide dismutase (SOD), 
glutathione peroxidase/reductase and catalase acting as a defense against lipid 
peroxidation in mammalian sperm. The malfunction of these enzyme activities 
could lead to a loss of the cell function [66].
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These enzymes catalytically eliminate reactive oxygen species from biological 
systems. Sperm themselves predominantly channel this enzymatic antioxidant 
[66]. Spermatozoa comprising of low intracellular antioxidant activity include 
superoxide dismutase (SOD), nuclear glutathione peroxidase (GPx), peroxiredoxin 
(PRDX), thioredoxin (TRX), and thioredoxin reductase (TRD) [67].
4.1.1 N-acetyl-cystein (NAC)
NAC serves as a precursor of glutathione (GSH) and has thus been employed as 
an antioxidant in many studies and trials.
The most important studies which demonstrate positive impact with  
varying doses in vitro are those reported by Baker et al., Oedaet al., and Lopes  
et al., [68–70].
Baker et al., witnessed decreased ROS generation and enhanced motility with 
doses ranging from 1 to 10 mmol [68]. Oeda et al. reported preserved motility with 
doses from 0.1 to 15 mg/ml [69] and Lopes et al. reported decreased DNA dam-
age with 0.1 mmol of NAC [70]. The three most relevant in vivo studies provided 
conflicting outcomes: Comhaire et al., did not find any enhancement in sperm 
parameters after 3 months’ administration of NAC (600 mg for 21 days) [71]; 
whilst the same dosage seemed to enhance sperm motility, volume, viscosity and 
oxidative status according to Ciftci et al., [72]. In another trial conducted on 468 
patients with idiopathic OAT treated for 6 months with 600 mg/day of NAC or 
200 mg/day of selenium or both, an enhancement in sperm count, motility and 
morphology was observed, with additive beneficial impact when both therapies 
were dispensed [73].
Figure 2. 
Enzymatic and non-enzymatic antioxidants.
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4.1.2 Glutathione peroxidase (GPx4)
Like peroxidase, Gpx4 is a member of the large family of peroxide reducing 
enzymes that employs glutathione as electron donor [74].
GPX4 exploits thiols in nuclear protein to reduce glutathione and may function 
as a redox regulation of sperm motility activation [75].
Sakai et al., found a correlation between undue production of glutathione 
peroxidase (GPx4) and infertility due to inhibition of ROS generation. GPx4 is not 
only an essential antioxidant enzyme required for sperm motility; it also plays a 
key role prior to capacitation [76]. However, while GPx4 shields sperm apoptosis, 
it decreases ROS which is an important factor for capacitation. Naturally occur-
ring mutations in the human GPX4 gene have been related to the pathogenesis of 
oligoasthenozoospermia [77].
4.1.3 L-Glutathion (GSH)
GSH is one of the most essential endogenous antioxidant, implicated in sustain-
ing the antioxidant balance in human tissues and directly engaged in the removal 
of ROS [78].
Due to its widely recognized antioxidant characteristics, GSH has been explored 
as a possible therapy for infertile patients. In vitro studies performed by Griveau 
and Le Lannou and by Lopes et al. have demonstrated a protective impact of 
10 mmol of GSH against DNA damage caused by ROS [70, 79].
In vivo studies, two trials performed by (Lenzi et al.; Lenzi et al.,) revealed 
that GSH exerted a positive, statistically significant impact on sperm parameters 
[80, 81]. The first, Lenzi et al., discovered that 600 mg of GSH dispensed every 
other day for 2 months increased the motility and morphology in 21 men treated 
with varicocele or male accessory gland infection [82]. The second, performed the 
following year on 10 infertile men with the same attributes, led to similar outcomes, 
although a significant upsurge in sperm concentration was also observed [80, 81].
Tail-beat frequency and the shielding effect of 5–10 and 1–10 mmol GSH in vitro 
against the disruption of sperm motility by activated polymorphonuclear leuko-
cytes has been reported [68, 83].
Parinaud et al., investigated the impact of Sperm-Fit, an antioxidant solution 
comprising of glucose and GSH, on sperm motility and showed that motility was 
well-preserved in leukocyte spermic samples, thus enhancing the possibility of 
recovering motile sperm after liquefaction and centrifugation [84].
Raijmakers et al., reported the presence of substantial amounts of GSH in the 
seminal plasma of both fertile and subfertile men. However, the median GSH 
concentrations were remarkable higher in fertile men in comparison with subfertile 
men. Furthermore, the concentrations of GSH in seminal plasma were directly cor-
related with sperm motility and inversely correlated with sperm morphology [85].
4.1.4 Superoxide dismutase (SOD)
There is some consensus on the helpful impacts of SOD on lipid peroxida-
tion in vitro. A plethora of studies, published in last two decades of 20th century 
i.e. between 1991 and 1998, (for a review Lombardo et al.,) described enhanced 
motility and decreased lipid peroxidation in samples dosed with between 87.7 and 
500 IU ml of SOD [86]. Similarly, Kovalski et al. reportedthat the incorporation of 
1 mg of SOD conserved motility [87].
In the contrary, other found no decreasein lipid peroxidation after the in corpo-
ration of between 100 and 500 IU ml SOD [88]. Besides, some investigators could 
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not affirm the impact of SOD on semen quality and sperm fertilizing potential [89]. 
However, the amount of endogenous antioxidants such as superoxide dismutase 
and catalase were also observed to be lower in smokers in comparison with fertile 
non-smokers [19, 90].
A direct correlation between the SOD activity and sperm damage and sperm 
motility was endorsed by several researchers [7].
4.1.5 Catalase (CAT)
Catalase represents one of the most effective natural enzymes which catalyzes 
the conversion of H2O2 into H2O and O2. CAT could play an essential role in male 
fertility and could turn out to be an excellent target for male infertility diagnosis.
In vitro investigations confirmed the positive impact of catalase in doses ranging 
from 0.008 to 0.1 mg/ml or from 50 to 2000 IU/ml on motility, peroxidation and 
DNA disruption [70, 79, 87].
However, Twigg et al., reported that the addition of 250, 500 or 2000 IU/ml of 
catalase to sperm samples did not provide any effect on lipid peroxidation. In the 
same study, no enhancement was observed in lipid peroxidation after the supple-
mentation of albumin at a dose of 0.3–10% [88].
Other researcherse valuated the effects produced by different types of antioxi-
dant therapies on semen quality in infertile males via measurement of CAT activity 
on seminal plasma through exogenous H2O2 degeneration. The results revealed that 
catalase activity improved after the administration of antioxidant treatments when 
compared to control samples without antioxidant administration [91–93].
Moreover, Catalase has also been shown to play a crucial role in male fertility. 
Its antioxidant activity prevents the upsurge of oxidative stress which can cause 
damage in sperm level, and accordingly, to reduced fertility. However, even though 
consensus prevails among most authors on the correlation of this scavenger with 
male fertility, it has only been investigated to a very limited degree of extent in this 
field [94].
4.1.6 Coenzyme Q10
A very strong relationship has been described to occur between sperm count, 
motility, and ubiquinol concentration in seminal fluid [95].
Lewin and Lavon employed coenzyme Q10 both in vivo and in vitro and 
revealed that the incorporation of 50 mmol in vitro caused a significant improve-
ment in motility, whilst in vivo incorporation of 60 mg/day for almost four months 
resulted in an enhancement in the fertilization rate but did not provide any impact 
on motility, morphology or concentration in 17 patients with decreased fertiliza-
tion rates after in vitro fertilization with intracytoplasmic sperm injection for male 
factor infertility [96].
A stimulating in vivo study conducted on 60 patients with idiopathic astheno-
zoospermia who were provided with either placebo or 200 mg daily of coenzyme 
Q10 showed a remarkable advancement in motility after 6 months of treatment; 
this enhancement was markedly decreased after a period of 3 months in treated 
subjects [97].
The exogenous incorporation of CoQ10 enhances both ubiquinone and ubiqui-
nol levels in semen and can be useful in increasing sperm kinetic features in patients 
suffering from idiopathic asthenozoospermia [97].
CoQ10 biosynthesis is highly active in the testes and elevated levels of ubiquinol 
are found in sperm [98, 99]. Gvozdjakova et al., revealed a direct relationship 
between seminal plasma CoQ10 total concentration and sperm motility [100].
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The name vitamin A includes both preformed vitamin A (retinol and its 
esters) and pro vitamin A carotenoids (mostly α-carotene, β-carotene, and 
β-cryptoxanthin). Retinol can be oxidized to retinal in a reversible manner, which 
provides all of the biological implications of retinol; or even further oxidized to 
retinoic acid, which represents the primary active metabolite of vitamin A [101].
Pro-vitamin A carotenoids can be endogenously transformed into retinoic 
acid whilst other carotenoids, including lutein, zeaxanthin, and lycopene, are not 
precursors of vitamin A but contain antioxidant capacity. Carotenoids are naturally 
found in fruits and vegetable. They impart the yellow, red and orange pigment in 
plant [102].
The most important phytochemical in the carotenoid family is lycopene which 
among the carotenoids, ranks as one of the most highest quencher of singlet 
oxygen. A combination of carotenoids, however, is highly potent as compared to 
individual compounds [103].
In in vitro models, β-carotene may act both as an antioxidant or a prooxi-
dant, depending upon the redox status of the biological environment in which it 
acts [104].
Comhaire et al., investigated the impact of a combination therapy of 180 mg day 
vitamin E and 30 mg day b-carotene on a group of 27 infertile men: ROS generation 
decreased significantly, although no significant enhancement in semen parameters 
was observed [71].
Zareba et al., evaluated the effect of regular carotenoid intake on the enhance-
ment of sperm quality in 189 young, healthy men. They evaluated semen volume, 
total sperm count, motility, and morphology after a period on antioxidant rich diet 
and observed that beta-carotene and lutein utilization elevated sperm motility [33]. 
However, high exploitation of some vitamins, such as vitamin A, may cause adverse 
reproductive outcomes [105].
4.2.1.1 Lycopene
Lycopene is one of the several constituents of the carotenoid family. Provitamin 
A carotenoids can be endogenously transformed into retinoic acid whilst other 
carotenoids, including lutein, zeaxanthin, and lycopene, which are not the precur-
sors of vitamin A but contain antioxidant capacity. Lycopene exhibits good antioxi-
dant activity includes singlet oxygen and free radical scavenging [106].
The presence of lycopene in human semen has been confirmed and its quantity 
can be enhanced after dietary intake with a natural source of Lycopene [107]. Also, 
very little is known about the efficacy of carotenoids, particularly that of lycopene—
a potent antioxidant and singlet oxygen quencher [108].
Zini et al., preincubated washed sperm suspensions with and without lycopene 
followed by incubation with H2O2 and presented a significant decrease in sperm 
mobility and significant elevation of sperm DNA defragmentation in lycopne 
untreated samples whilst the treated samples showed a significant decrease in 
sperm DNA defragmentation [109].
Ghyasvand et al., performed another study to evaluate the levels of lycopene, 
beta-carotene and retinol in serum and their relationship with sperm DNA disrup-
tion and lipid peroxidation in infertile and normo-spermic males, and concluded 
that lycopene, beta-carotene, and retinol can decrease sperm DNA fragmentation 
and lipid peroxidation via their antioxidant effect [110].
Antioxidants - Benefits, Sources, Mechanisms of Action
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4.2.1.2 Lutein and zeaxanthin
Comhaire et al., conducted a study involving 30 subfertile men which were 
treated with 16 mg a day of astaxanthin, a carotenoid which is not transformed into 
vitamin A in humans, for 3 months and did not find any, significant enhancement 
in concentration, motility, morphology or volume in the 11 treated men compared 
with the 19 control patients [111].
Intriguingly, Ming-Chieh Li, et al., found an unusual and unexpected inverse 
relationship of β-carotene administration from foods and of lutein and zeaxanthin 
administration with live birth rates. Within the observed administration ranges, 
total consumption of vitamins A, C and E before initiating infertility treatment 
with ART was not correlated with live birth rates [112].
4.2.2 Vitamin B (folic acid)
Folic Acid is a B-vitamin which is necessary for the synthesis of DNA and 
transfer of RNA.
The micronutrients folate and zinc are closely related with semen quality. Blood 
plasma and seminal plasma levels of folate are positively related with sperm concen-
tration and count [113, 114].
Moreover, folic acid, the synthetic form of folate, effectively scavenges oxidizing 
free radicals and inhibits lipid peroxidation [115].
The evidence on the impact of folate on fertility is unclear. Wong et al., reported 
that in vivo utilization of folic acid, alone or combined with zinc sulphate (5 and 
66 mg day respectively), enhanced sperm concentration and count in their formerly 
discussed controlled trial. The results were, however, significant only for the 103 
infertile men involved in the study, whilst the 107 fertile men did not present any 
enhancement in sperm parameters [116].
Also, nutritional utilization of antioxidants, such as vitamins C and E, and 
β-carotene, and micronutrients, such as folate and zinc, have been shown to be 
critically essential for normal semen quality and reproductive function as con-
firmed by a large number of studies in both animals and humans [55].
Ebisch et al., showed that administration of zinc and folic acid enhancesnot only 
sperm quality but also the outcome of varicocelectomy [117].
Other researchers have revealed that a low folate concentration in seminal 
plasma is correlated with increased sperm DNA damage in infertile men [118].
Schisterman et al., designed and conducted a trial involving 2,370 couples plan-
ning infertility treatments. The men were assigned arbitrarily and received either 
a placebo or a daily supplement comprising of 5 milligrams of folic acid and 30 
milligrams of zinc. The results indicated that the live births did not alter significantly 
among the two groups: 404 (34%) in the supplement group and 416 (35%) in the 
placebo group. Similarly, the groups did not show difference among various semen 
parameters, such as sperm motility, morphology and total count. However, the frac-
tion of sperm DNA fragmentation was elevated in the supplement group (29.7%), 
when compared to the placebo group (27.2%). Men in the supplement group also pre-
sented an elevated proportion of gastrointestinal symptoms, when compared to the 
placebo group: abdominal discomfort (6% vs. 3%), nausea (4% vs. 2%) and vomiting 
(3% vs. 1%). The authors reported that these dietary supplements have a very little to 
no impact on fertility and may even provoke mild gastrointestinal symptoms [119].
4.2.3 Vitamin C
Ascorbic acid represents the main natural water-soluble antioxidant and is an essen-
tial dietary nutriment. This water-soluble antioxidant is an essential dietary nutrient.
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Beside, its high potency for scavenging ROS [120], Vit-C serves as an excellent 
source of electrons, providing an electron to free radicals such as superoxides and 
hydroxyls radicals, which decreases their reactivity and damages [121].
Ascorbic acid exhibits both antioxidant and prooxidant properties depending 
upon the amount [122]. As an exogenous antioxidant in semen, ascorbic acid played 
a very crucial role in controlling the oxidative stress [47].
In an extensive study comprising of 30 infertile but healthy men, daily intake 
of 200 mg and 100 mg vitamin C enhanced sperm count by 112 and 140 percent 
respectively. Intriguingly the concentration of ascorbic acid in the seminal plasma is 
10-fold higher than the serum [123].
The concentration of ascorbic acid in the seminal plasma was observed to be 
negatively correlated with reactive oxygen species activity in sperm of infertile 
men, and the reduced ascorbic acid intake was correlated with an elevated oxidative 
damage in the sperm of healthy men [124].
Hughes et al., reported the significance of vitamins C (300-600 mmol/l) and 
E (30–60 mmol/l) in protecting sperm DNA integrity in Percoll preparations; 
however, this combination has generated contrasting outcomes with excessive DNA 
damage, which is likely associated to pro-oxidant effects [125].
Donnelly et al. reported decreased H2O2-induced ROS production and DNA 
damage after the utilization of both vitamin C (300 and 600 mmol/l) and vitamin E 
(40 and 60 mmol/l) to normozoospermic and asthenozoospermic samples [126].
Vitamin C acts as a cofactor for various key enzymes. It assists in the metabolic 
processes of folic acid, tyrosine and tryptophan [127]. In cells, ascorbic acid inter-
acts with glutathione in maintaining the reduced form of tocopherol [128].
Kini et al., reported a significant increase in the testicular GSH and SOD 
level but a reduction in testicular MDA level after pre-treatment of rats with 
Vitamin-C before cadmium chloride exposure [129]. Similar outcomes were 
observed by Behairy et al. [130]. In addition, vitamin C is vital in protecting from 
oxidative damage to the sperm and steroid cells of the Leydig cells and in the 
sperm chamber [131].
A potent and combined action of vitamin C and E has been observed to protect 
the spermatozoa against peroxidative insult and DNA fragmentation [132].
Vitamin C reduces the inter chain disulphide bridges in protamines opening 
the cysteine net and subsequently causing DNA decondensation in spermatozoa 
[54, 133, 134].
4.2.4 Vitamin D
Vitamin D plays a significant role in regulating both male and female fertil-
ity [135]. The quality of spermatozoa strongly dependen upon vitamin D [136]. 
Vitamin D is also responsible for retaining sperm motility [137]. Low fertility 
rates have also been credited to low vitamin D levels in the serum of males [138]. 
Vitamin D deficiency, in contrast, decreases the probabilities of success when 
undergoing assisted reproductive technology [139–141]. Islamian et al. investi-
gated the combined effect of vitamin D complement and docosahexaenoic acid 
on oxidative stress indices of semen in asthenospermic men. The outcome showed 
that the combined treatment with fatty acid complement, docosahexaenoic 
acid and vitamin E in asthenospermic men decreased oxidative stress in seminal 
plasma [142].
4.2.5 Vitamin E (α-tocopherol)
Vitamin E represents a fat-soluble antioxidant molecule which serves as a major 
chain breaking antioxidant in membranes.
Antioxidants - Benefits, Sources, Mechanisms of Action
12
Numerous studies were conducted on vitamin E. The first clinical tri-
als showed that vitamin E supplementation increase the fertilization rates by 
decreasing lipid peroxidation potential [143]. Kodama et al., reported elevated 
sperm concentration and decreased DNA damage in 36 infertile patients who 
underwent 2 months of therapy with vitamin E (200 mg day), vitamin C 
(200 mg day) and glutathione (GSH; 400 mg day), with no significant enhance-
ment in motility or morphology [144].
Similarly, in another study in which a co-administration of vitamin E and 
selenium for six months resulted in a significant increase in sperm motility and 
a decreased percentage of defective spermatozoa in comparison with pre-sup-
plementation period [145, 146]. Besides, it has also been reported that vitamin E 
decreases the oxvidative damage resulting an increase in the fertilization rate [71].
A plethora of research has been dedicated to show that antioxidants such as 
vitamins E and C and carnitines assist in reducing oxidative stress by quench-
ing free radicals [42]. Greco et al. showed a significant enhancement in 38 men 
with increased sperm DNA fragmentation after 2 months of combined therapy 
comprising of 1 g of vitamin C and 1 g of vitamin E daily: clinical pregnancy and 
implantation rates presented a remarkable increase after the second attempt in 
comparison with an initial failed intracytoplasmic sperm injection attempt before 
treatment [53].
Also, vitamin E as an antioxidant may directly quench free radicals and together 
with CoQ10 shield lipid membranes from peroxidative insult [147].
Moslemi et al., showed that supplementation of vitamin E can significantly 
decrease lipid peroxidation in seminal plasma, enhance sperm motility and boost 
pregnancy occurrence [148].
However, in a Meta-analysis, four studies confirmed that it had a very little or no 
impact on semen parameters, whilst beneficial effects were shown in the remaining 
18 studies [86].
4.2.6 Carnitine
The antioxidant activity of carnitines shields against lipid peroxidation of cells 
membrane, stimulating a large number of in vivo trials examining their impact on 
sperm parameters.
In the trial conducted by Costa and colleagues [149], 3 g day of L-carnitine 
was provided to 100 asthenozoospermic men. After 4 months of treatment, a 
significant enhancement in sperm concentration, motility and morphology was 
observed.
Balercia et al., evaluated various doses of L-carnitine and acetyl-L-carnitine (3 g 
of L-carnitine, 3 g of acetyl-L-carnitine, or 2 g L carnitine and 1 g acetyl-L-carni-
tine daily), showing enhanced sperm motility in asthenozoospermic subjects [150].
Also, Carnitine supplementation has been reported to enhance sperm concen-
tration, mobility, viability, morphology, and total antioxidative capacity [151].
In contrast, Sigman et al., did not find any enhancements in semen parameters 
in 26 men diagnosed with asthenozoospermia and underwent 6 months of therapy 
with L-carnitine and L-acetyl-carnitine with 2 and 1 g day, respectively [152].
Gvozdjáková et al., demonstrated a beneficial impact of treatment with a com-
bination of different antioxidants (carnitine with ubiquinol, vitamins E and C) on 
sperm density, which improved by 39.8% after 3 months of therapy and by 78.0% 
after 6 months of therapy and sperm motility was enhanced. Sperm pathology 
reduced in 25.8% after 3-month treatment [153].
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4.2.7 Flavonoids
Flavonoids comprise of a very large heterogeneous group of benzopyran deriva-
tives found naturally in fruits, vegetables, and herbs. This group of plant antioxi-
dants has many beneficial health effects.
Flavonoids exhibit a positive health effect in cancer and neurodegenerative 
diseases, owing to their innate free radical-scavenging activities [154].
These flavonoid glycosides serve as extremely potent free radical scavengers 
[155, 156]. Some of the most popular and well-known antioxidant flavonoids also 
serve as prooxidants even when a transition metal is available [157].
Quercetinis one of the most abundant natural flavonoids found in a large variety 
of fruits and vegetables [158, 159].
The pentahydroxy flavone protect from oxidative injury and cell death by 
scavenging free radicals, donating hydrogen compound, quenching singlet oxygen, 
and shielding lipid peroxidation or chelating metal ions [160].
4.2.8 Selenium
Selenium is a very important trace mineral which is highly essential for the 
human body, including the immune system, cognitive function, and male and 
female fertility.
According to the United States Office of Dietary Supplements, it participates in 
the metabolism of thyroid hormone and DNA synthesis, and protects against infec-
tion and oxidative damage.
Selenium significantly contributes in the construction of the mitochondrial 
protective shield in sperm cells and interferes with the condition and function of 
sperm, and is potent in the treatment of impaired fertility [161].
Searching for a concrete proof of the advantages of in vivo selenium therapy is 
problematic, since various studies with a range of dosages have resulted in conflict-
ing results.
Iwanier and Zachara did not find any positive impact after 3 months of therapy 
with selenium at a dose of 200 mg day in 33 subfertile men [162].
In 1998, Scott and his colleagues executed a trial on a group of 64 men (compris-
ing of 46 men diagnosed with OAT and 16 classified as subfertile), dispensing sele-
nium alone or in combination with vitamins A, C and E at daily doses of 100 mg, 
1 mg, 10 mg and 15 mg respectively. No significant enhancement was observed 
in sperm concentration even after 3 months, although motility was increased in 
treated subjects [163].
However, most of the other studies have claimed enhancements in several 
parameters after several months of combined therapy with selenium and other 
antioxidants.
Vezina et al., reported that combination of selenium and vitamin E enhanced the 
sperm motility, morphology and viability, and the concentration, however, did not 
alter significantly, as previously discussed [145].
Keskes-Ammar et al., and Safarinejad employed a combination therapy—sele-
nium and vitamin E in the former and selenium and NAC in the latter—which 
enhanced the motility in both studies and improved the sperm count and morphol-
ogy in the latter [73, 164].
Besides, it has been demonstrated that Selenium is a fundamental element for 
semen quality and plays an important function in keeping reproductive  
condition [31, 48].
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4.2.9 Zinc
Zinc is an important micronutrient which also serves as a multifunctional co-
factor for more than 80 metallo enzymes involved in DNA transcription and protein 
synthesis [117]. Moreover, zinc finger proteins are extensively involved in the 
genetic expression of steroid hormone receptors [165], and it also has antioxidant 
[166] and anti-apoptotic properties [167].
An interesting correlation was also revealed between the level of Zn in serum 
and semen in oligozoospermic infertile men, with significantly decreased levels of 
Zn in serum and semen of men with fertility problems [168]. Zinc levels in seminal 
plasma have also been positively correlated with sperm concentration and motility 
in the literature [169, 170].
The Zinc in seminal plasma also serves as antioxidant and anti-bacterial agent 
which shields the semen from heavy metals accumulation [171].
Two studies were published in which ZnSO4 was utilized: in the first,  
500 mg/day of Zinc sulphate (ZnSO4) was dispensed to 100 asthenozoospermic 
men for 3 months, and a significant upturn in sperm count, motility and mem-
brane integrity was observed [172]. The second study, published 10 years later, 
employed a combination of drugs and Zinc sulphate (ZnSO4) has been postulated 
as an infertility treatment, although only a few studies have shown its impact on 
semen parameters when applied in vivo [173].
Wong et al. observed an elevated sperm count and enhanced semen concentra-
tion in a controlled trial with 103 infertile and 107 fertile men who had consumed 
5 mg folic acid and 66 mg ZnSO4 per day for 6 months, either alone or in combina-
tion but no enhancements in any of the sperm parameters, most notably concentra-
tion were observed [116].
Due to its key role in the processes of DNA compaction, administration of this 
micronutrient i.e. Zn was very successful in enhancing sperm morphology and 
DNA integrity in patients suffering from prostate abnormalities [174, 175].
High seminal Zn levels may provide harmful effect on the spermatozoa-zona 
pellucida-induced acrosome reaction in normozoospermic men [176].
Zinc, is extensively involved in processes of reproduction, not only in the 
hormone metabolism but also in sperm formation and in the regulation of sperm 
viability and motility [31].
4.2.10 Manganese (Mn)
Manganese (Mn2+) is one of the most abundant element which is widely distrib-
uted in soil, air, water, and food [177].
It is known by its ability to quench the superoxide anions and hydroxyl radicals 
and due to its chain breaking capacity [178].
The structural flexibility induced by Mn2+ is also vital for enzyme dynamics, 
since Mn is crucial for RNA polymerization [179].
Therefore, Manganese is an essential metal which serves as a co-factor for 
several enzymes and plays several important biological functions [180]. Mn2+ may 
stimulate the enzymes of glutathione cycle and interact with the total thiols (TSH), 
glutathione reduced (GSH), glutathione oxidized (GSSG) contents in human 
spermatozoa. It reduces the generation of thiobarbituric acid reactive substances. 
In several organisms, elevated intracellular manganese shields against oxidative 
damage via unknown pathways [181].
Few studies have evaluated the impact of Mn exposure on male reproductive 
health. Lafond et al., showed that decreased Mn levels in seminal plasma from men 
with diminished sperm densities [182]. Besides, Mn2+ is a very potent stimulator of 
sperm motility through the stimulation of adenylate cyclase activity [183].
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In addition, Manganese accelerates the progressive motility of human washed 
sperm in a time and dose dependent manner [184]. Moreover, it is proposed that 
anti-oxidative activity of Mn2+ stabilizes the plasma membrane, thereby sustaining 
the membrane integrity and viability [185].
Also, Mn is a necessary element for humans, but although it has several crucial 
functions for normal reproductive health, overexposure to Mn2 may be harmful to 
reproductive health [176, 186].
4.2.11 Pentoxyfilline (PTX)
PTX is a derivative of xanthine and a methylxanthine, it is a vasodilating com-
pound which increases red blood cell deformability, prevents from inflammatory 
reactions and decreases blood viscosity by avoiding platelet aggregation [187].
Pentoxifylline serves as a phosphodiesterase inhibitor and shields the cells from 
lipid peroxidation by H2O2, therefore it may be helpful to minimize H2O2 induced 
embryo damage and improve IVF outcome [188].
Controversial outcomes were presented in various studies. Some studies 
reported that the pentoxifylline exerts a beneficial effect on sperm parameters, 
by decreasing the superoxide anion generation [189–191] or by minimizing lipid 
peroxidation [191, 192]. However, Twigg et al., did not find any enhancement in 
lipid peroxidation after the utilization of 3.6 mmol/l of pentoxifylline [88].
Safarinejad carried out a randomized controlled trial on a population compris-
ing of men with idiopathic Oligoasthenoteratozoospermie (OAT). He investigated 
the response of semen parameters to supplementation with 400 mg of PTX twice 
daily for a 24-week therapy phase followed by a 12-week therapy-free period. The 
outcomes of that study revealed a significant enhancement in seminal parameters 
such as concentration, motility, and morphology [91].
It was also reported that PTX exhibited a positive impact on ICSI outcomes, 
including fertilization, embryo quality, and pregnancy rates, in asthenozoospermic 
patients [187].
In conclusion, antioxidants intake separately or combined for at least three 
monthes is advisable for patients who planning to undergoing ART therapy.
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